Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Inglewood, CA
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Inglewood, CA
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
La Jolla, CA
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Los Angeles, CA
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Thousand Oaks, CA
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Tustin, CA
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Danbury, CT
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Newark, DE
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Newark, DE
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Atlantis, FL
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Atlantis, FL
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Aventura, FL
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Aventura, FL
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Clearwater, FL
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Miami, FL
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Tampa, FL
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Atlanta, GA
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Macon, GA
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Macon, GA
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Chicago, IL
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Auburn, ME
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Auburn, ME
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Baltimore, MD
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Detroit, MI
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Petoskey, MI
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Petoskey, MI
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Minneapolis, MN
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Minneapolis, MN
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
St Louis, MO
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Las Vegas, NV
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Bronx, NY
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Durham, NC
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Portland, OR
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Greenville, SC
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Nashville, TN
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Tullahoma, TN
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Tullahoma, TN
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Houston, TX
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Seattle, WA
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Madison, WI
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
Clinical Research Facility
mi
from
Cortlandt Manor, NY
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
Clinical Research Facility
mi
from
Cortlandt Manor, NY
Click here to add this to my saved trials
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated:  4/26/2016
mi
from
Darlinghurst,
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure.
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 4/26/2016
mi
from
Darlinghurst,
Click here to add this to my saved trials
Database of Patients Undergoing Cardiac Computed Tomographic Angiography at William Beaumont Hospital (CT DATABASE)
Database of Patients Undergoing Cardiac Computed Tomographic Angiography (CCTA)at William Beaumont Hospital
Status: Enrolling
Updated:  4/27/2016
Beaumont Health System - Royal Oak
mi
from
Royal Oak, MI
Database of Patients Undergoing Cardiac Computed Tomographic Angiography at William Beaumont Hospital (CT DATABASE)
Database of Patients Undergoing Cardiac Computed Tomographic Angiography (CCTA)at William Beaumont Hospital
Status: Enrolling
Updated: 4/27/2016
Beaumont Health System - Royal Oak
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
Status: Enrolling
Updated:  4/27/2016
Cooper University Hospital
mi
from
Camden, NJ
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
Status: Enrolling
Updated: 4/27/2016
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
Status: Enrolling
Updated:  4/27/2016
New York-Presbyterian Hospital
mi
from
New York, NY
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
Status: Enrolling
Updated: 4/27/2016
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
Status: Enrolling
Updated:  4/27/2016
Städtische Kliniken Neuss - Lukaskrankenhaus - GmbH
mi
from
Preußenstr. 84,41464 Neuss,
Clinical Investigation for Safety and Efficacy Study of CELT ACD Arterial Closure Device
Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003
Status: Enrolling
Updated: 4/27/2016
Städtische Kliniken Neuss - Lukaskrankenhaus - GmbH
mi
from
Preußenstr. 84,41464 Neuss,
Click here to add this to my saved trials
Myocardial Infarction Genes (MI-GENES) Study
Myocardial Infarction Genes (MI-GENES) Study - Using Genomic Data to Refine Risk Assessment for Heart Attack
Status: Enrolling
Updated:  5/2/2016
The Mayo Clinic
mi
from
Rochester, MN
Myocardial Infarction Genes (MI-GENES) Study
Myocardial Infarction Genes (MI-GENES) Study - Using Genomic Data to Refine Risk Assessment for Heart Attack
Status: Enrolling
Updated: 5/2/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
AP-05-002 A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug)in the Treatment of Diabetic Macular Edema
A Randomized, Placebo-Controlled, Parallel, Double-Masked Study to Evaluate the Efficacy and Safety of Two Doses of Oral Optina in Adult Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  5/4/2016
Vaughan Clift
mi
from
Englewood, CO
AP-05-002 A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug)in the Treatment of Diabetic Macular Edema
A Randomized, Placebo-Controlled, Parallel, Double-Masked Study to Evaluate the Efficacy and Safety of Two Doses of Oral Optina in Adult Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 5/4/2016
Vaughan Clift
mi
from
Englewood, CO
Click here to add this to my saved trials
Pilot Study of the QI Device for Monitoring of Patients With Congestive Heart Failure
Pilot Study of the Quanttus Device for Monitoring of Patients With Congestive Heart Failure
Status: Enrolling
Updated:  5/4/2016
Scripps Health
mi
from
San Diego, CA
Pilot Study of the QI Device for Monitoring of Patients With Congestive Heart Failure
Pilot Study of the Quanttus Device for Monitoring of Patients With Congestive Heart Failure
Status: Enrolling
Updated: 5/4/2016
Scripps Health
mi
from
San Diego, CA
Click here to add this to my saved trials
Serial Phlebotomy in Voluntary Blood Donors
Serial Phlebotomy in Voluntary Blood Donors
Status: Enrolling
Updated:  5/4/2016
New York University Langone Medical Center
mi
from
New York, NY
Serial Phlebotomy in Voluntary Blood Donors
Serial Phlebotomy in Voluntary Blood Donors
Status: Enrolling
Updated: 5/4/2016
New York University Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Prenatal Effects of Congenital Heart Disease (CHD) on Neurodevelopmental Outcome
The Prenatal Effects of Congenital Heart Disease on Neurodevelopmental Outcome
Status: Enrolling
Updated:  5/5/2016
Columbia University College of Physicians & Surgeons, Morgan Stanley Children's Hospital of New York
mi
from
New York, NY
Prenatal Effects of Congenital Heart Disease (CHD) on Neurodevelopmental Outcome
The Prenatal Effects of Congenital Heart Disease on Neurodevelopmental Outcome
Status: Enrolling
Updated: 5/5/2016
Columbia University College of Physicians & Surgeons, Morgan Stanley Children's Hospital of New York
mi
from
New York, NY
Click here to add this to my saved trials
Genotype-Guided Warfarin Therapy Trial
Randomized Controlled Trial of Genotype-Guided Dosing of Warfarin Therapy
Status: Enrolling
Updated:  5/5/2016
UNC Hospitals, UNC Anticoagulation Clinic at the Ambulatory Care Center (ACC), UNC Family Medicine Center Anti-coagulation Clinic
mi
from
Chapel Hill, NC
Genotype-Guided Warfarin Therapy Trial
Randomized Controlled Trial of Genotype-Guided Dosing of Warfarin Therapy
Status: Enrolling
Updated: 5/5/2016
UNC Hospitals, UNC Anticoagulation Clinic at the Ambulatory Care Center (ACC), UNC Family Medicine Center Anti-coagulation Clinic
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Physiological Study of Human Cholesterol Metabolism and Excretion
Reverse Cholesterol Transport in Humans
Status: Enrolling
Updated:  5/5/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Physiological Study of Human Cholesterol Metabolism and Excretion
Reverse Cholesterol Transport in Humans
Status: Enrolling
Updated: 5/5/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Physiological Effects of Grape Seed Extract in Diastolic Heart Failure
GRAPe Seed Extract and Ventriculovascular Investigation in Normal Ejection-Fraction Heart Failure
Status: Enrolling
Updated:  5/10/2016
University of Michigan
mi
from
Ann Arbor, MI
Physiological Effects of Grape Seed Extract in Diastolic Heart Failure
GRAPe Seed Extract and Ventriculovascular Investigation in Normal Ejection-Fraction Heart Failure
Status: Enrolling
Updated: 5/10/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Better Effectiveness After Transition - Heart Failure
Variations in Care: Comparing Heart Failure Care Transition Intervention Effects
Status: Enrolling
Updated:  5/10/2016
University of California Davis
mi
from
Davis, CA
Better Effectiveness After Transition - Heart Failure
Variations in Care: Comparing Heart Failure Care Transition Intervention Effects
Status: Enrolling
Updated: 5/10/2016
University of California Davis
mi
from
Davis, CA
Click here to add this to my saved trials
Better Effectiveness After Transition - Heart Failure
Variations in Care: Comparing Heart Failure Care Transition Intervention Effects
Status: Enrolling
Updated:  5/10/2016
University of California, Irvine
mi
from
Irvine, CA
Better Effectiveness After Transition - Heart Failure
Variations in Care: Comparing Heart Failure Care Transition Intervention Effects
Status: Enrolling
Updated: 5/10/2016
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials